{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:02:38Z","timestamp":1773288158699,"version":"3.50.1"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A price increase of pyrimethamine tablets in the United States has made the life-saving drug difficult to acquire for hospitalized patients who need it most. We report the successful use of a pyrimethamine oral suspension compounded from an economical bulk powder in a patient with acute toxoplasmic encephalitis.<\/jats:p>","DOI":"10.1093\/ofid\/ofy055","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T17:25:40Z","timestamp":1524072340000},"source":"Crossref","is-referenced-by-count":5,"title":["Successful Treatment of Cerebral Toxoplasmosis Using Pyrimethamine Oral Solution Compounded From Inexpensive Bulk Powder"],"prefix":"10.1093","volume":"5","author":[{"given":"Hayley A","family":"Hodgson","sequence":"first","affiliation":[{"name":"Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois"},{"name":"Department of Pharmacy, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeyong","family":"Sim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemil","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Aziz","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoona","family":"Rhee","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul O","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Johnson City Medical Center, Johnson City, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel","family":"Jhobalia","sequence":"additional","affiliation":[{"name":"Rush Specialty Drug Solutions, Rush University Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Shields","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila K","family":"Wang","sequence":"additional","affiliation":[{"name":"Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois"},{"name":"Department of Pharmacy, Department of Internal Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"2020081004174375600_CIT0001","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00002030-199209000-00021","article-title":"Levels of pyrimethamine in serum and penetration into brain tissue in humans","volume":"6","author":"Leport","year":"1992","journal-title":"AIDS"},{"key":"2020081004174375600_CIT0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann Intern Med"},{"key":"2020081004174375600_CIT0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","article-title":"Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS","volume":"22","author":"Katlama","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020081004174375600_CIT0004","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","author":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents"},{"key":"2020081004174375600_CIT0005","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/B978-1-4557-4801-3.00280-0","article-title":"Toxoplasma gondii","volume-title":"Mandell, Douglas, and Bennett\u2019s Principle and Practice of Infectious Diseases","author":"Montoya","year":"2015","edition":"8th ed"},{"key":"2020081004174375600_CIT0006","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/AAC.42.6.1346","article-title":"Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group","volume":"42","author":"Torres","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081004174375600_CIT0007","doi-asserted-by":"crossref","first-page":"583","DOI":"10.4269\/ajtmh.2009.80.583","article-title":"Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994\u20132006","volume":"80","author":"Beraud","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"2020081004174375600_CIT0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1545109707301244","article-title":"Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients","volume":"7","author":"Kongsaengdao","year":"2008","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"2020081004174375600_CIT0009","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/173.5.1294","article-title":"Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome","volume":"173","author":"Van Delden","year":"1996","journal-title":"J Infect Dis"},{"key":"2020081004174375600_CIT0010","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/ajhp\/54.23.2714","article-title":"Stability of pyrimethamine in a liquid dosage formulation stored for three months","volume":"54","author":"Nahata","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"2020081004174375600_CIT0011","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2146\/ajhp160551","article-title":"Stability of a pyrimethamine suspension compounded from bulk powder","volume":"74","author":"Lewis","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"2020081004174375600_CIT0012","volume-title":"United States Pharmacopeia and National Formulary (USP 37 \u2013 NF 32)","author":"US Pharmacopeia","year":"2014"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/4\/ofy055\/33591356\/ofy055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/4\/ofy055\/33591356\/ofy055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:57:34Z","timestamp":1660967854000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy055\/4976000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy055","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4,1]]},"article-number":"ofy055"}}